Article
The Kroger Co today announced it will acquire the outstanding shares of Axium Pharmacy Holdings, Inc, a leading specialty pharmacy, to create a merger of the 2 companies.
The Kroger Co today announced it will acquire the outstanding shares of Axium Pharmacy Holdings, Inc, a leading specialty pharmacy, to create a merger of the 2 companies.
Founded in 2000, Axium provides drug therapies and patient-support services to treat chronic, genetic and other complex medical conditions such as cancer, Hepatitis C, Rheumatoid Arthritis, Multiple Sclerosis and numerous other chronic care conditions. This partnership gives Kroger significantly enhanced capabilities to serve customers who require complex drug therapies, and to deliver those therapies at greater value to customers and insurance payers. Financial terms were not disclosed.
“Kroger and Axium are a strategic fit as we look to enter the high-growth specialty pharmacy business,” said Lincoln Lutz, Kroger’s vice president of corporate pharmacy. “The combination of Axium’s expertise and Kroger’s 1950 pharmacy locations, 91 Little Clinic locations, and pharmacists who provide health coaching, biometric screening and other wellness services will deliver positive health outcomes for our patients, cost savings for insurance payers, and unique services for physicians.”
Strong Growth Opportunity
Specialty pharmacy is the primary area of growth in pharmaceuticals. Revenue for specialty drugs has grown from $17 Billion in 2000 to $104 Billion in 2011, and is projected to grow to $135 Billion in 2014. In 2011, 80% of new drugs approved by the FDA were specialty drugs. Currently more than 700 specialty drugs are in the pipeline for approval.
“This partnership supports Kroger’s long-term growth plans, with strong return on invested capital,” said Rodney McMullen, Kroger’s president and chief operating officer.
Kroger announced a new long-term growth strategy at an investor’s conference in October.
Axium Healthcare Pharmacy
Headquartered in Lake Mary, Florida, Axium is one of the nation’s largest independent providers of specialty pharmacy services, offering a range of clinical services to patients with complex chronic conditions. Through its additional pharmacy locations in Puerto Rico, Tennessee, and Mississippi, Axium provides comprehensive specialty pharmacy services to patients throughout the United States and Puerto Rico.
Axium seamlessly addresses the clinical, administrative and financial needs of patients, referring physicians, insurance payers and pharmaceutical manufacturers.
Axium will continue to operate as an independent company within the Kroger family.
“We are excited to partner with Kroger to deliver specialty pharmacy services to their customers,” said Mark Montgomery, Axium’s president and chief executive officer. “We believe this relationship will create efficiencies that will reduce costs, drive growth and improve the overall quality of our combined healthcare services.”
Mr. Montgomery will continue to lead Axium. He has been with the company for nine years, the last six as president and CEO. With more than 25 years of healthcare leadership experience, he has held instrumental management roles with multiple leading nationwide specialty pharmacy providers.
“We are very excited to welcome Axium’s leadership team and all 160 current associates to the Kroger family,” said Mr. Lutz. “Mark and the team have built a great company that is positioned for growth.”
The transaction is contingent on typical conditions of closing, including any required approval of regulatory authorities. Edge Healthcare Partners, LLC served as Axium's financial advisor for the pending merger.
SOURCE: Kroger
FDA Approves Bimekizumab-Bkzx as Treatment for Hidradenitis Suppurativa